To observe the distribution of different types of Helicobacter pylori (H.pylori) infection in non-atrophic gastritis, atrophic gastritis and intestinal metaplasia.

From January 2015 to January 2017, 457 hospitalized patients with gastritis were collected. All the inpatients received ¹⁴C-urea breath test (¹⁴C-UBT), H. pylori antibody typing detection, anesthesia gastroendoscopy and pathological analysis of biopsies. According to the results of H. pylori antibody typing, all patients were divided into type Ⅰ H. pylori infection group, type Ⅱ H. pylori infection group and H. pylori negative group. The relation among different types of H. pylori infection, age and pathological type were analyzed. Analysis of variance and chi-square test were performed for statistical analysis.

The mean age of patients in type Ⅰ H. pylori infection group (n=135), type Ⅱ H. pylori infection group (n=98) and H. pylori negative group (n=224) in patients with non-atrophic gastritis was (47.5±9.0), (49.0±9.0) and (52.0±11.0) years, respectively, which were lower than those of patients with atrophy gastritis ((56.8±10.3), (57.5±12.4) and (62.6±10.4) years, respectively) and patients with intestinal metaplasia ((59.2±11.1), (57.5±12.6) and (57.8±10.0) years, respectively), and the differences were statistically significant (F=17.90, 6.82 and 18.30, all P<0.01). The proportion of patients with non-atrophic gastritis in H. pylori negative group, type Ⅱ H. pylori infection group and type Ⅰ H. pylori infection group decreased in turn (56.3%, 126/224; 40.8%, 40/98 and 34.8%, 47/135, respectively), and the differences were statistically significant (χ²=18.44, P<0.01). The proportion of patients with intestinal metaplasia in H. pylori negative group, type Ⅱ H. pylori infection group and type Ⅰ H. pylori infection group increased in turn (23.2%, 52/224; 26.5%, 26/98 and 42.2%, 57/135), and the difference was statistically significant (χ²=11.44, P=0.003). There was no significant difference in the proportion of patients with atrophic gastritis among H. pylori negative group, type Ⅱ H. pylori infection group and type Ⅰ H. pylori infection group (20.5%, 46/224; 32.7%, 32/98 and 23.0%, 31/135; χ²=5.60, P=0.061).

Gastric atrophy is easily induced in patients with H. pylori infection. In patients without symptoms, H. pylori should be eradicated before gastric atrophy, which can provide the greatest benefit to the patients. Different types of H. pylori infection have different role in the progress of atrophic gastritis. Type Ⅰ H. pylori infection accelerate the progress of atrophic gastritis, especially from atrophic gastritis to intestinal metaplasia, which should be actively eradicated.

Helicobacter pylori antibody; Gastritis, atrophic; Intestinal metaplasia; Pathological classification